The big picture: The German healthcare system excels at diagnosis but fails at daily adherence, leaving millions of chronic patients—particularly those with kidney disease (CKD)—unsupported between doctor visits. Oska Health addresses this “messy middle” by combining human health coaches with automated platforms to manage multimorbid patients in their daily lives.
Why it matters:
- Economic Burden: 70% of German healthcare spending is tied to chronic illness, driven by poor treatment adherence and lack of lifestyle changes.
- Scalability: Traditional clinics lack the resources for continuous follow-ups; Oska scales this by integrating directly with over 20 insurance providers, making the service free for patients.
- Growth: The company reports an 8x growth rate over the last two years, signaling high demand from insurers for cost-effective intervention.
How it works:
- Hybrid Coaching: Patients receive evidence-based guidance via video-calls, chat, and a dedicated app focusing on medication adherence and behavioral science.
- MDR Certified: Operating as a certified medical device, the platform translates medical recommendations into daily habits for patients with CKD, diabetes, and hypertension.
- Provider Integration: Plugs into the existing healthcare infrastructure without requiring doctors to install new software.
The catch: Oska’s reliance on human health coaches is its greatest strength in driving adherence, but also its primary scaling risk. While human-led intervention yields high engagement, it carries significantly higher operational overhead than the pure-software models seen in digital neurorehabilitation. To maintain its current growth trajectory, Oska must prove that its automated backend can progressively reduce the “human-to-patient” ratio without sacrificing the clinical outcomes that insurers are currently subsidizing.
Key Details
- Funding: €11M (Seed)
- Lead: Capricorn Partners, SwissHealth Ventures
- CEO: Niklas Best
- Sector: HealthTech / Chronic Care
